PFE · News · 20260922N

Guidance and Outlook

PFIZER INC · 2026-09-22 · Importance 75 · Surprise 60

Third-party reports state that Pfizer raised its 2026 revenue guidance to $61.5 billion. The outlook is supported by non-COVID portfolio strength, acquired products, and new-product ramps, while COVID-19 product sales guidance was reduced. Analysts also cited Vyndaqel softness and the rollout of most-favored-nation Medicaid pricing as near-term uncertainties.